14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Mon, 6 May 2024

Trading levels for ARVN

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 33.84 4.36 %
R2 33.30 2.67 %
R1 32.96 1.63 %
Current price: 32.43
Support S1 31.87 -1.74 %
S2 31.53 -2.78 %
S3 30.98 -4.46 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 37.26 14.89 %
R2 36.29 11.90 %
R1 34.72 7.06 %
Current price 32.43
Support S1 32.37 -0.185%
S2 31.90 -1.63%
S3 31.77 -2.04%

ARVN Predictions History

2 years ago
JS predicted that ARVN for 2022-02-08 is going $72.11 (0.87%)

2 years ago
arhanda81.300345 predicted that ARVN for 2022-02-08 is going

Rank:

4 years ago
merchant predicted that ARVN for 2019-09-27 is going $24.49 (4.04%)

Rank:

4 years ago
Rookie predicted that ARVN for 2019-09-24 is going $24.69 (4.31%)

Rank:

4 years ago
2poJeff predicted that ARVN for 2019-09-23 is going $24.50 (0.04%)

4 years ago
StockVader predicted that ARVN for 2019-09-19 is going

4 years ago
2poJeff predicted that ARVN for 2019-09-19 is going $24.63 (1.32%)

4 years ago
merchant predicted that ARVN for 2019-09-18 is going $24.98 (0.69%)

Rank:

4 years ago
PumpTheseNumbers predicted that ARVN for 2019-09-18 is going $24.50 (-1.25%)

4 years ago
2poJeff predicted that ARVN for 2019-09-18 is going

Click to get the best stock tips daily for free!

About Arvinas Inc.

Arvinas. Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor (AR) protein for the treatment of men with metastatic castration-resistant prostate cancer (mCRPC); ARV... ARVN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT